PHASE I, OPEN-LABEL, DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF KETOCONAZOLE ON SINGLE DOSE MIRABEGRON (YM178) ORAL CONTROLLED ABSORPTION SYSTEM (OCAS) IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Sawamoto, T. [1 ]
Lee, J. [1 ]
Alak, A. [1 ]
Meijer, J. [2 ]
Roy, M. [1 ]
Zha, J. [1 ]
van Gelderen, M. [2 ]
Marion, A. [3 ]
Keirns, J. [1 ]
机构：
[1] Astellas Global Res Dev, Deerfield, IL USA
[2] Astellas Global Res Dev, Leiderdorp, Netherlands
[3] MDS Pharma Serv US Inc, Omaha, NE USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study
    Alberto Papi
    Andrea F. D. Di Stefano
    Milko Radicioni
    Advances in Therapy, 2021, 38 : 468 - 478
  • [22] Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study
    Papi, Alberto
    Di Stefano, Andrea F. D.
    Radicioni, Milko
    ADVANCES IN THERAPY, 2021, 38 (01) : 468 - 478
  • [23] Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study
    Wang, Wei
    Qian, Hong-jie
    Xin, Liang
    Zhang, Meng-qi
    Lu, Dong-ying
    Jin, Jie-mei
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Yu, Chen
    Wang, Yi-ping
    Zhu, Fu
    Liu, Yun
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 593 - 599
  • [24] A PHASE I, SINGLE-DOSE, RANDOMIZED, OPEN-LABEL, CROSSOVER, RELATIVE BIOAVAILABILITY, AND FOOD EFFECT STUDY OF BELVARAFENIB IN HEALTHY SUBJECTS.
    Malhi, V.
    Monemi, S.
    Dolton, M.
    Kapp, A.
    Angelaud, R.
    Zhang, W.
    Eng-Wong, J.
    Sullivan, C.
    Mueller, L.
    Musib, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S43 - S43
  • [25] Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study
    Wei Wang
    Hong-jie Qian
    Liang Xin
    Meng-qi Zhang
    Dong-ying Lu
    Jie-mei Jin
    Gang-yi Liu
    Jing-ying Jia
    Hong-chao Zheng
    Chen Yu
    Yi-ping Wang
    Fu Zhu
    Yun Liu
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 593 - 599
  • [26] A phase I, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib
    Gao, Ling
    Yamamiya, Ikuo
    Pinti, Mark
    Rondon, Juan Carlos
    Marbury, Thomas
    Tomlinson, Gareth
    Makris, Lukas
    Hangai, Nanae
    Wacheck, Volker
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (09): : 1713 - 1724
  • [27] Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study
    Helen Jenkins
    Richard Jenkins
    Alain Patat
    Clinical Drug Investigation, 2017, 37 : 311 - 316
  • [28] Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study
    Jenkins, Helen
    Jenkins, Richard
    Patat, Alain
    CLINICAL DRUG INVESTIGATION, 2017, 37 (03) : 311 - 316
  • [29] Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men
    Scheers, Ellen
    Leclercq, Laurent
    de Jong, Jan
    Bode, Nini
    Bockx, Marc
    Laenen, Aline
    Cuyckens, Filip
    Skee, Donna
    Murphy, Joe
    Sukbuntherng, Juthamas
    Mannens, Geert
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (02) : 289 - 297
  • [30] A phase-I open-label study of the absorption, metabolism, and excretion of (14C)-ramelteon (TAK-375) following a single oral dose in healthy male subjects
    Hibberd, M
    Stevenson, SJ
    SLEEP, 2004, 27 : 54 - 54
12345